Addressing Risk with Early Recognition: Reducing the Severity of IV Harm

Peripheral IV infiltration and extravasation events (PIVIEs) remain one of the most frequent—and most harmful—complications in neonatal intensive care. Research shows that routine observation often fails to catch early warning signs, delaying intervention and increasing risk.

Neonatal vascular access expert Roland (Matheus) van Rens, recently presented new clinical evidence demonstrating how continuous optical monitoring can reduce the severity of PIVIEs and help protect the most vulnerable patients.

Drawing on data from three neonatal studies, including a recently published retrospective cohort of more than 32,000 IV insertions analyzed, Roland discusses how combining early detection with the 7 Rights framework for vascular access improves safety and outcomes in the NICU.

Session addressed:

• The prevalence and impact of PIVIEs in neonatal care

• How to apply the 7 Rights to improve vascular access outcomes

• The pitfalls of routine observation methods—and how to overcome them

• Evidence that sensor-based monitoring reduces injury severity and supports safer practice

Watch now to see how NICUs are integrating standardized grading, risk stratification, and optical monitoring to prevent the most serious IV injuries.

Liked this presentation? Tell us what your thoughts are by using this survey link.

Resources:

WEBINAR: Reducing the severity of IV harm: addressing the risks of peripheral IV therapy with early recognition. [Download]

Evaluation of optical sensor technology for the early detection of peripheral intravenous infiltration in neonates: a retrospective cohort study. [Download]

Peripheral intravenous therapy infiltration/extravasation (PIVIE) risks and the potential for earlier notification of events using a novel sensor technology in a neonatal population. [Download]

A new approach for early recognition of peripheral intravenous (PIV) infiltration: a pilot appraisal of a sensor technology in a neonatal population [Download]